GlassScriptPhysician profile
Alberto Interian
NPI 1386673663
$39,070.61
in general payments reported to CMS, 2019-2025
25 companies · $8,391 in 2025
The $8,391 reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,661 · 2020: $3,696 · 2021: $4,900 · 2022: $4,554 · 2023: $8,518 · 2024: $4,351 · 2025: $8,391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16K · Travel and Lodging: $5,487.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,772.45 |
| Travel and Lodging | $5,487.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $19,103.71 | 2019-2025 | Aveir, Jot Dx, Gallant |
| Medtronic, INC. | $8,598.74 | 2021-2025 | Micra, Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan |
| Boston Scientific Corporation | $4,780.58 | 2022-2025 | Farapulse, Watchman Flx, General - Therapies |
| Biotronik INC. | $1,819.71 | 2019-2022 | |
| Biosense Webster, INC. | $1,019.07 | 2019 | |
| Medtronic Vascular, INC. | $835.70 | 2019-2020 | |
| Pfizer INC. | $360.61 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $359.73 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $352.04 | 2019-2025 | Camzyos, Eliquis |
| Atricure, INC. | $325.27 | 2023-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $270.53 | 2019-2024 | Lifevest |
| Impulse Dynamics (USA) INC. | $236.72 | 2021-2024 | Optimizer |
| Janssen Pharmaceuticals, INC | $212.90 | 2019-2024 | Xarelto |
| Tela Bio, INC. | $144.14 | 2022 | |
| Kestra Medical Technology Services, INC. | $136.13 | 2023-2025 | Assure Wcd |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $85.50 | 2021-2024 | Wainua |
| Novartis Pharmaceuticals Corporation | $84.43 | 2019-2024 | |
| Irhythm Technologies, INC. | $80.98 | 2023 | Zio Xt Patch |
| Philips North America LLC | $73.74 | 2024-2025 | Diagnostic Ecg Service, (Ck4) Mcot |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.76 | 2019 | |
| Vital Connect, INC | $39.11 | 2024-2025 | Vitalpatch Rtm |
| Baxter Healthcare | $31.87 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Cardiva Medical, INC. | $30.38 | 2021 | |
| Cardiofocus, INC. | $25.95 | 2023 | Heartlight System |
| Cordis US Corp. | $19.31 | 2025 | Mynx Control Venous |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alberto Interian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.